drugset / Trial / NCT02707315
A Study of Pre-Operative Cyberknife in Patients With Potentially Resectable Pancreas Cancer
NaSingle-groupOpen-labelTreatment
Summary
This study is evaluating stereotactic radiosurgery (CyberKnife) plus chemotherapy for the treatment of potentially resectable adenocarcinoma of the pancreas
Timeline
- Start
- 2013-01
- Primary completion
- 2016-12
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Gemcitabine | Small molecule | 1000 mg/m2 | — |